1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Infections, Salmonella in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, J; Badía, J; Baldoma, L; Egea, L; Giménez, R; Lúcia, D; Modolell, I | 1 |
| Chaussade, S; Denizot, Y | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Infections, Salmonella
| Article | Year |
|---|---|
Increased production of the ether-lipid platelet-activating factor in intestinal epithelial cells infected by Salmonella enteritidis.
Topics: Adult; Aged; Caco-2 Cells; Colon; Epithelial Cells; Escherichia coli Infections; Escherichia coli O157; Ethers; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Platelet Activating Factor; Salmonella enteritidis; Salmonella Infections | 2008 |
Tumor necrosis factor and platelet activating factor in stool during salmonellosis.
Topics: Feces; Humans; Platelet Activating Factor; Salmonella Infections; Tumor Necrosis Factor-alpha | 1994 |